Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection.
Fischer JC, Balz V, Jazmati D, Bölke E, Freise NF, Keitel V, Feldt T, Jensen BO, Bode J, Lüdde T, Häussinger D, Adams O, Schneider EM, Enczmann J, Rox JM, Hermsen D, Schulze-Bosse K, Kindgen-Milles D, Knoefel WT, van Griensven M, Haussmann J, Tamaskovics B, Plettenberg C, Scheckenbach K, Corradini S, Pedoto A, Maas K, Schmidt L, Grebe O, Esposito I, Ehrhardt A, Peiper M, Buhren BA, Calles C, Stöhr A, Gerber PA, Lichtenberg A, Schelzig H, Flaig Y, Rezazadeh A, Budach W, Matuschek C. Fischer JC, et al. Among authors: ehrhardt a. Eur J Med Res. 2022 Nov 21;27(1):255. doi: 10.1186/s40001-022-00864-z. Eur J Med Res. 2022. PMID: 36411478 Free PMC article.
Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
Wang X, Kerkmann L, Hetzel M, Windmann S, Trilling M, Zhang W, Ehrhardt A, Bayer W. Wang X, et al. Among authors: ehrhardt a. J Virol. 2022 Nov 23;96(22):e0113322. doi: 10.1128/jvi.01133-22. Epub 2022 Nov 7. J Virol. 2022. PMID: 36342295 Free PMC article.
Effect of farnesyltransferase inhibitors on SARS-CoV-2.
Weber L, Mautner L, Hoyos M, Ehrhardt A, Baiker A, Bachmann HS. Weber L, et al. Among authors: ehrhardt a. J Glob Antimicrob Resist. 2023 Mar;32:164-166. doi: 10.1016/j.jgar.2022.11.011. Epub 2022 Dec 1. J Glob Antimicrob Resist. 2023. PMID: 36462736 Free PMC article.
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.
Tedbury PR, Manfredi C, Degenhardt F, Conway J, Horwath MC, McCracken C, Sorscher AJ, Moreau S, Wright C, Edwards C, Brewer J, Guarner J, de Wit E, Williamson BN, Suthar MS, Ong YT, Roback JD, Alter DN, Holter JC, Karlsen TH, Sacchi N, Romero-Gómez M, Invernizzi P, Fernández J, Buti M, Albillos A, Julià A, Valenti L, Asselta R, Banales JM, Bujanda L, de Cid R, Franke A; Severe COVID-19 GWAS group; Sarafianos SG, Hong JS, Sorscher EJ, Ehrhardt A. Tedbury PR, et al. Among authors: ehrhardt a. FASEB J. 2023 Nov;37(11):e23220. doi: 10.1096/fj.202300077R. FASEB J. 2023. PMID: 37801035
337 results